Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.587NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.232NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.5.2.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCYNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-180.147US
JN.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
EK.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
HV.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BU.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-15690.9US
BA.5.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BF.7.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XBJ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used